BYAH Company Profile and Key Details

BYAH has shown mixed momentum, losing -0.12% over the past week and -57.1% over the past quarter, though year-to-date performance is up 1.38%. Short-term trend indicators are bullishly aligned (SMA20 -49.98%, SMA50 -73.44%, SMA200 -99.23%). The stock’s 14-day RSI is 23.41 (weak momentum), while the ATR of 0.73 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -99.92% below its high and over 0.0% above its low. Average 10-day trading volume of 14.60 thousand shares is below the 3-month average of 69.21 thousand, indicating normal recent market interest.

Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ:BYAH) closed at $1.33 USD, gaining $0.10 (8.13%) from the previous close of $1.23. The stock is currently mid-range between its 52-week high and low $0.93 and $2.07 thousand. With a market capitalization of about $901.02 thousand, Park Ha Biological Technology Co., Ltd. Ordinary Shares is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.55). Key stats such as the average daily volume over the past year has been around 106.89 thousand shares, in line with its 52-week average. Headquartered in Wuxi, None, Park Ha Biological Technology Co., Ltd. Ordinary Shares operates in the Consumer Cyclical sector and the Personal Products & Services industry. Led by CEO Xiaoqiu Zhang, the company employs approximately 31 people and listed since October 24, 2025. The company is an investment holding company that develops skincare products under the “Park Ha” brand in the People’s Republic of China, through its subsidiaries operating in direct product sales and franchise services.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Our AI price prediction model suggests that Park Ha Biological Technology Co., Ltd. Ordinary Shares stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.63%, with price expected at $1.25 by May 21, 2026, within a range of $1.21 to $1.29 3-Month Outlook: Projected fall of -98.37%, reaching $0.02 by August 05, 2026, with a range of $0.00 to $0.13. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by May 07, 2027, within a range of $0.00 to $0.11.

Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ:BYAH) shares are flat 1.38% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Park Ha Biological Technology Co., Ltd. Ordinary Shares trading at a premium to the broader market with a P/E of -0.03. Our AI forecast model points to short-term strength (1.63% over two weeks), a medium-term fall (-98.37% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Park Ha Biological Technology Co., Ltd. Ordinary Shares trades at a P/E ratio of -0.03, slightly below the S&P 500 average, with a price-to-sales ratio of 0.33 and a price-to-book ratio of 0.18 suggesting the stock is closer to book value. The P/FCF stands at -277.14, also below market averages.